A DUAL MET - VEGF MODULATOR FOR TREATING OSTEOLYTIC BONE METASTASES MET-VEGF

摘要

This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteolytic bone metastases, with a dual inhibitor of MET and VEGF.